期刊文献+

氟哌噻吨美利曲辛片治疗继发性BPPV老年患者残余头晕症状的疗效观察 被引量:4

Cutative Effect of Flupentixol and Melitracen Tablets on Residual Diziness of Gerontal Patients with Secondary Benign Paroxysmal Positional Vertigo
原文传递
导出
摘要 目的探讨氟哌噻吨美利曲辛片对继发性良性阵发性位置性眩晕(bnign proxysmal psitional vrtigo,BPPV)老年患者残余头晕症状的影响。方法收集2014年1月—2016年9月嘉兴市第一医院神经内科治疗的84例继发性BPPV老年患者(年龄>65周岁)的临床资料,分为氟哌噻吨美利曲辛片治疗组(n=42)和常规治疗组(n=42)。比较2组残余头晕的持续时间及治疗前,治疗后第3天、第1周、第2周的眩晕障碍量表(Dizziness Handicap Inventory,DHI)分数。结果和常规治疗组相比,氟哌噻吨美利曲辛片治疗组残余头晕症状持续时间明显较短(P=0.002)。复位成功后,与常规治疗组相比,氟哌噻吨美利曲辛片组治疗后第1周和第2周的DHI分数明显降低(P分别为0.040和0.030)。结论氟哌噻吨美利曲辛片治疗继发性BPPV,可使残余头晕的持续时间明显缩短,治疗1周和2周后DHI评分降低。 OBJECTIVE To investigate the influence of Flupentixol and Melitracen tablets in residual diziness of gerontal patients with secondary benign paroxysmal positional vertigo(BPPV). METHODS The clinical data of 84 gerontal patients(age 〉65) with secondary BPPV who received treatment in the neurology clinic of the First Hospital of Jiaxing were collected. These patients were divided into two groups: Flupentixol and Melitracen tablets group(n=42) and conventional treatment group(n=42). The duration of residual diziness and the score of Dizziness Handicap Inventory(DHI) were analyzed before treatment, three days, one week and two weeks after treatment. RESULTS The duration of residual diziness in Flupentixol and Melitracen tablets group was shorter than conventional treatment group(P=0.002). Compared with conventional treatment group after resetting success, the score of Flupentixol and Melitracen tablets group significantly decreased for one week and two week after treatment(P=0.040 and P=0.030, respectively). CONCLUSION Flupentixol and Melitracen tablets group have shorter duration of residual diziness, lower score of DHI of one week or two weeks after treatment.
作者 胡进 许俊杰 傅伟达 HU Jin;XU Junjie;FU Weida(Zhejiang Chinese Medical University, Hangzhou 310053, China;Department of Internal Neurology, The First Hospital of Jiaxing, Jiaxing 314000, China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2018年第6期888-890,共3页 Chinese Journal of Modern Applied Pharmacy
基金 浙江省卫生适宜技术成果转化计划项目(2015ZHB013) 嘉兴市第一医院壹计划项目(2017-YA-18)
关键词 氟哌噻吨美利曲辛片 继发性良性阵发性位置性眩晕 残余头晕 眩晕障碍量表 Flupentixol and Melitracen tablets secondary benign paroxysmal positional vertigo residual diziness DizzinessHandicap Inventory
  • 相关文献

参考文献7

二级参考文献71

  • 1无.良性阵发性位置性眩晕的诊断依据和疗效评估(2006年,贵阳)[J].中华耳鼻咽喉头颈外科杂志,2007,42(3):163-164. 被引量:776
  • 2庄建华,黄坚,赵忠新,赵瑛,周辉,王文昭,田国红.主观性良性阵发性位置性眩晕的临床表现和治疗[J].中华耳鼻咽喉头颈外科杂志,2007,42(3):177-180. 被引量:23
  • 3卢怡,高秀文.加味左金丸治疗慢性浅表性胃炎34例[J].齐齐哈尔医学院学报,2007,28(13):1580-1581. 被引量:7
  • 4Woodworth B A, Gillepie M B, Lambert P R. The canalith reposition- ing procedure for benign positional vertigo:a meta-analysis J . La- ryngoscope, 2004,114:1143-1146.
  • 5Epley JM. New dimensions of benign paroxysmal positional vertigo J. Otolaryngol Head Neck Surg,1980,88:599-605.
  • 6Semont A, Freyss G ,Vitte E. Curing the BPPV with a liberatory ma- neuver J. Adv Otorhinolaryngol,1988,42:290-293.
  • 7Lempert T, Tiel-Wilck k. A positional maneuver for treatment of horizontal-canal benign positional vertigo J . Laryngoscope,1996, 106:476-478.
  • 8Gufoni M, Mastrosimone L, Di Nasso F. Repositioning maneuver in benign paroxysmal vertigo of horizontal semicircular canal J . ActaOtorhinolaryngol Ita1,1998,18:363-367.
  • 9Yon Brevem M, Radtke A ,Lezius F ,et al. Epidemiology of benign paroxysmal positional verigo: a population based study. J Neurol Neurosurg Psychiatry ,2007,78(7):710-715.
  • 10Neuhauser HK , Lempert T . Vertigo: epidemiologic aspects J . Semin Neurol, 2009,29 (5):473-481.

共引文献190

同被引文献40

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部